# Benefits of a Cannabidiolic Acid Topical Cream for the Treatment of Restless Leg Syndrome

> **NCT06570941** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Synthonics Inc** · enrollment: 10 (estimated)

## Conditions studied

- Restless Legs Syndrome

## Interventions

- **DRUG:** Chylobinoid Topical Cream

## Key facts

- **NCT ID:** NCT06570941
- **Lead sponsor:** Synthonics Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-03-01
- **Primary completion:** 2024-09-30
- **Final completion:** 2024-10-31
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2024-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06570941

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06570941, "Benefits of a Cannabidiolic Acid Topical Cream for the Treatment of Restless Leg Syndrome". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06570941. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*